Vaginal dryness is one of the most talked-about symptoms of menopause. And yet, most women1 who experience it suffer in silence — not because they don’t know it’s common, but because they’ve been led to believe it’s just something to endure.
It isn’t. And here’s what makes it worse: vaginal dryness is only one piece of a much bigger picture. It belongs to a syndrome — one that affects your daily comfort, your intimacy, and your urinary health. And unlike hot flashes, it doesn’t fade on its own. Left untreated, it tends to get worse as we age.
The good news is that effective, targeted treatments exist but too few women are told about them and are reluctant to use them. Don’t worry, we’ll get you all the information you need to know your options.
What is vaginal atrophy?
“Vaginal atrophy” is an older clinical term for the thinning, drying, and change of vaginal tissue that happens when reproductive hormone levels drop. Today, most clinicians use a more accurate term: genitourinary syndrome of menopause (GSM).
The update matters. Vaginal tissue doesn’t change in isolation — the vulva, urethra, and bladder are all sensitive to estrogen and androgen, and all can be affected. GSM captures that full picture. It also steps away from the finality of “atrophy,” which implies an irreversible process. It isn’t.
GSM is extremely common. Studies2 suggest that 40–54% of postmenopausal women experience bothersome GSM symptoms. Yet more than half never use any treatment to address them, and around 70% never even bring it up with their doctor3. Most assume it’s just aging and that there’s nothing that can be done about it. Think again.
Worth knowing: Unlike many menopause symptoms that ease with time, GSM tends to progress without treatment. The earlier you address it, the easier it is to manage.
Why menopause causes vaginal dryness
The short answer: hormonal decline.
Estrogen is what keeps vaginal tissue thick, elastic, and lubricated. It maintains an acidic vaginal environment that promotes optimal vaginal flora. It supports the collagen in surrounding structures. When estrogen levels decline — as they do in perimenopause and menopause — all of that changes.
Androgens (including testosterone) also play a role. As these hormones decrease alongside estrogen, tissue begins to thin, the vaginal walls become less elastic, and natural lubrication decreases significantly.
GSM can also occur outside of menopause, in any context where hormones are temporarily suppressed — during breastfeeding, for example, or as a side effect of certain medications. But for most women, it’s menopause that brings it on and sustains it.
Symptoms of vaginal atrophy: more than just dryness
This is where many women are surprised. They’ve heard about vaginal dryness, but GSM is a syndrome, meaning it involves a cluster of symptoms across three distinct areas.
Genital symptoms
- Vaginal dryness
- Itching or irritation
- A burning sensation, particularly with daily activities
- Changes in vaginal discharge
Sexual symptoms
- Reduced natural lubrication during arousal
- Loss of vaginal elasticity
- Pain during or after intercourse (dyspareunia)
- Tearing or spotting during sex
- Reduced sensation or difficulty reaching orgasm
Urinary symptoms
- Burning or discomfort when urinating
- Increased urgency or frequency
- Recurrent urinary tract infections (UTIs)
Some women have primarily urinary symptoms with no dryness at all. Others experience sexual discomfort without any daily irritation. The presentation is individual — which is exactly why GSM can go unrecognized for so long.
Can vaginal atrophy cause UTIs?
Yes. As hormonal levels drop, the tissue lining the urethra and bladder becomes thinner and more vulnerable to bacterial infection. Recurrent UTIs in menopausal women are often a sign of GSM rather than a separate problem — and treating GSM directly has been shown to reduce their frequency by 50%.
How vaginal atrophy affects libido and intimacy
You know that moment when your partner reaches over and your first thought is please, not tonight? Your body learns fast. And what it learns is: this hurts. The desire doesn’t vanish overnight — it just quietly stops showing up.
When vaginal tissue has thinned and lost elasticity, when lubrication is insufficient, intercourse creates microtraumas (small tears and friction) that cause burning, irritation, and pain. Your body learns the association quickly. Desire drops. Avoidance grows.
The impact on intimate relationships can be significant, not because anything is broken, but because an untreated physical symptom is creating a cascade of emotional and relational strain. Many women describe guilt, disconnection from their partners, or a quiet grief around the loss of something that used to feel good and effortless.
Treating GSM directly addresses this cycle at its source. When sex stops being something to dread, desire often returns.
Over-the-counter options: moisturizers and lubricants
For mild to moderate symptoms, products you can pick up at the pharmacy without a prescription are a reasonable and accessible first step. The key is understanding what each product does — because they serve different purposes and work best when used together.
Vaginal moisturizers
Moisturizers are designed for ongoing tissue hydration. Applied directly to the vaginal walls several times a week (not just before sex), they work by maintaining baseline moisture levels in the tissue. Most contain hyaluronic acid, which has solid evidence for reducing dryness and irritation over time.
Think of it like a good skincare routine. You don’t put on moisturizer the night before a big event and call it done. You use it consistently, and the results show up weeks later, quietly, in the fact that things just feel better.
Lubricants
Lubricants are simpler — they’re there for the occasion, not the maintenance. Water-based lubricants are the most versatile and compatible with all condoms and sex toys. Silicone-based lubricants last longer and may be preferable for women with significant dryness — but silicone formulas are not compatible with some condoms or any silicone sex toys. If either applies to you, water-based is the safer default.
Moisturizer is the unglamorous one you use on a regular basis. Lubricant is for date night. You need both.
What pharmacy products can and can’t do
Non-prescription products manage symptoms — they don’t address the underlying cause, which is hormonal decline. For many women, they provide adequate relief. For others, especially those with moderate to severe symptoms, they’re not enough on their own.
When should you see a provider?
If you’ve been using a moisturizer and lubricant consistently and still struggling, or if your symptoms are affecting your relationships, sleep, or daily comfort, it’s worth talking to a healthcare provider about hormonal options.
Intravaginal estrogen: the most effective treatment
If there’s one thing most clinicians agree on, it’s this: local estrogen therapy is the gold standard treatment for GSM.
“Local” is the operative word. Unlike systemic hormone therapy (MHT taken as a pill or patch to manage hot flashes, sleep, and mood), intravaginal estrogen is applied directly to vaginal tissue. It works where the problem is, without significant absorption into the bloodstream.
This distinction matters because the safety concerns many women associate with hormone therapy (increased clotting risk, breast cancer associations) are linked to systemic exposure. Local intravaginal estrogen has a very different safety profile. Studies consistently show that blood estrogen levels remain within postmenopausal range during treatment.
The evidence for efficacy is strong. Local estrogen restores tissue thickness and elasticity, improves lubrication, rebalances vaginal pH, and significantly reduces pain during sex. For urinary symptoms, local estrogen has also been shown to reduce the frequency of recurrent UTIs in menopausal women — a meaningful benefit given how disruptive (and antibiotic-dependent) those infections can become.
Is vaginal estrogen safe long-term?
Yes. Local hormonal treatments are safe for ongoing use, and most clinical guidelines support continued use for as long as symptoms are present. GSM is a chronic condition — it persists as long as estrogen levels remain low, which after menopause is indefinitely. Stopping treatment typically means symptoms return.
Vaginal estrogen: formats, DHEA, and what to expect
There’s no single “vaginal estrogen.” Several formulations are available, and the right one depends on your symptoms, preferences, and medical history.
Estrogen-based options
Vaginal tablets or suppositories: small inserts applied with or without an applicator. Typically used daily for two weeks, then twice weekly for maintenance. Discreet and well-tolerated.
Estrogen creams: applied with an applicator or directly to the vulva. Useful for external symptoms (irritation, dryness at the vaginal opening). Can also be used for internal symptoms with applicator delivery.
Vaginal rings: a small, flexible ring that releases a steady low dose of estrogen over 90 days. Insert it, forget it, get on with your life.
DHEA (dehydroepiandrosterone) — an alternative pathway
DHEA inserts (also known as prasterone) take a slightly different approach. Rather than delivering estrogen directly, they deliver DHEA — a precursor hormone that is converted locally into both estrogen and testosterone within the vaginal tissue.
This matters because testosterone plays a role in tissue health and sexual sensation. DHEA inserts provide both hormonal components with a single product, without meaningful systemic absorption of either.
Side effects of vaginal estrogen: what is normal
The return of vaginal discharge is the most commonly reported side effect of local hormonal treatment — and it’s worth reframing. Discharge after starting local estrogen or DHEA is not a warning sign. It’s evidence the treatment is working. Healthy, well-hydrated vaginal tissue naturally produces secretions. What registers as a “side effect” is actually your tissue recovering its normal function.
A slightly increased risk of yeast infections has been reported in a small number of women, particularly those with a prior history. A more moist and hormonal rich environment is marginally more hospitable to yeast. This is uncommon, easily treated if it occurs, and rarely a reason to discontinue treatment.
What about women with a history of hormone-sensitive cancer?
The evidence here is stronger than many women realize. Multiple well-conducted studies have found that local estrogen is safe even for women with a history of breast cancer, because the systemic absorption is minimal enough that it doesn’t meaningfully raise estrogen levels in the bloodstream.
That said, not all providers are equally up to date on this. If your GP or oncologist is hesitant, it’s worth seeking out a provider who focuses on menopause and knows the current literature. You don’t need permission, you need the right conversation with the right person.
You don’t have to live with this
GSM is common, progressive without treatment, and highly treatable. It affects physical comfort, intimacy, urinary health, and quality of life. And yet it remains one of the most undertreated conditions in menopause care — largely because women are still being told their symptoms are normal and to just push through.
If you’ve been managing these symptoms alone, or been told they’re just part of getting older, you deserve better. Coral connects you with a care team that focuses on menopause and knows how to treat it, including local hormonal treatments for GSM, available virtually across Canada.
Book a call and see if Coral is right for you
Disclaimer: The information provided here is for informational purposes only. It is not intended as medical advice. Always consult with your doctor or healthcare provider to determine what is best for your individual health needs.
- While we use the word “women” for simplicity, we recognize that menopause and perimenopause can affect people of many gender identities. Our goal is to support everyone who experiences these changes. ↩︎
- Garcia de Arriba S, Grüntkemeier L, Häuser M, May TW, Masur C, Stute P. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study. PLoS One. 2022 May 12;17(5):e0266633. doi: 10.1371/journal.pon ↩︎
- Carlson K, Nguyen H. Genitourinary Syndrome of Menopause. [Updated 2024 Oct 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559297/ ↩︎
